Biophytis Obtains a New 10M€ Loan Structure With Kreos Capital
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 22, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris: ALBPS) (the "Company"...
Day: November 22, 2021
Empower Clinics Releases Q3 2021 Results with 372% Year-Over-Year Revenue Growth
The Company Reports nine-month year-over-year revenue growth of 1,349%VANCOUVER, BC / ACCESSWIRE November 22, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF)...
Pharnext Appoints Dr. Burkhard Blank as New Chief Medical Officer and Head of Research & Development
Dr. Burkhard Blank brings more than 25 years of industry experience and will support the ongoing PREMIER pivotal Phase III...
Meet the BIOMEDevice Silicon Valley 2021 Keynote Lineup: Two Expert-led Panels Set to Explore the Convergence of Advanced Tech and Healthcare
Tune in to two days of forward-looking and inspirational keynote panels presented by eight of the industry’s most prominent leaders...
XVIVO Expands its Management Team by Appointing Jaya Tiwari to Vice President Clinical and Regulatory Affairs for the US
GOTHENBURG, SE / ACCESSWIRE / November 22, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)To further optimize the commercialization process...
Limitless Venture Group, Inc. Posts Record Revenue for The Third Quarter 2021, The Sixth Consecutive Record Revenue Quarter and has Already More than Doubled 2020 Annual Revenues, Equaling $.0732/Share in Revenues
TULSA, OK / ACCESSWIRE / November 22, 2021 / Limitless Venture Group, Inc. (OTC PINK:LVGI) ("LVGI" or the "Company"), a...
Halberd Successfully Eradicates TNF-a, a Major Contributing Factor to Alzheimer’s Disease
JACKSON CENTER, PA / ACCESSWIRE / November 22, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 85% of Tumor Necrosis...
StageZero Life Sciences ARISTOTLE(R) Multi-Cancer Blood Test Now Available in Greater Toronto Area
First-ever mRNA multi-cancer panel simultaneously screens for multiple cancers from a single sample of bloodTORONTO, ON and RICHMOND, VA /...
Clearmind Medicine to Pursue Dual Listing on Nasdaq
Toronto, Ontario, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or...
Former CPO of Convoy and Marchex Joins H1 as Chief Operating Officer
Ziad Ismail Joins H1 During Period of High Growth for Leading Global Healthcare Network Ziad Ismail, COO of H1 Former...
Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist, dapiglutide
Company announcement – No. 70 / 2021 Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist,...
Allied Corp Signs Contract for the Sale of Retail Ready Products Into Mexico
KELOWNA, British Columbia, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Auxly Acquires 100% Ownership of Sunens and Amends Credit Facility
Sunens Farms The state-of-the-art Sunens facility, acquired by Auxly Cannabis Group. Auxly acquires remaining equity interest and secures 100% ownership...
RespireRx Pharmaceuticals Inc. Announces CEO’s OTC Venture Market Podcast
Glen Rock, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader...
Promising COVID-19 Therapeutic Drug to start Phase 3 Clinical Trial in the United States
Pulmonem and the Research Institute of the McGill University Health Centre announce recruitment of first US-based patientsDIEPPE, New Brunswick, Nov....
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignancies
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC)
Following the fifth and final DSMC review, committee has concluded no concerns with cytisinicline safety or Phase 3 trial conductSEATTLE,...
Sharps Compliance Adds Transportation Industry Veteran Gary R. Enzor to Board of Directors
HOUSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national...
POINT Biopharma to Host Virtual Education Event on December 6, 2021
POINT to host inaugural educational event highlighting radiopharmaceuticals, their therapeutic benefit, and commercial considerations Register online at https://hub.pointbiopharma.com/dec2021 INDIANAPOLIS, Nov....
180 Life Sciences Corp. Expands Patent Portfolio
New IP Relates to a Method for Treating Chronic Pain or Associated Conditions/Symptoms with Novel Compositions Including Certain Phenyl Substituted...